Determinants of SARS-CoV-2 Contagiousness in Household Contacts of Symptomatic Adult Index Cases.

SARS-CoV-2 age contagiousness cycle threshold household transmission risk viral load

Journal

Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977

Informations de publication

Date de publication:
2022
Historique:
received: 05 12 2021
accepted: 15 02 2022
entrez: 18 4 2022
pubmed: 19 4 2022
medline: 19 4 2022
Statut: epublish

Résumé

Identifying determinants of the novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) transmission in settings of contagion is fundamental to inform containment strategies. We assessed SARS-CoV-2 cycle threshold value (Ct) from the first diagnostic nasal-pharyngeal swab of symptomatic index cases and which demographic or clinical characteristics among cases and contacts are associated with transmission risk within households. This is a retrospective prevalence study on secondary SARS-CoV-2 cases (SC) among the household contacts of symptomatic adult index cases randomly sampled from all the SARS-CoV-2-positive diagnostic nasopharyngeal swabs analyzed at our regional referral hospital (Amedeo di Savoia Hospital, Turin, Italy) in March, 2020. Index cases underwent a telephone survey to collect their demographic and clinical data and all their household contacts. The Ct value of RdRp gene from the first diagnostic swab of index cases was recorded and index cases were grouped according to Ct tertiles (A < first tertile, first ≤ B ≤ second tertile, C ≥ second tertile). Index ( In confined transmission settings such as households, PCR Ct values may inform on the contagiousness of infected subjects and age may modulate transmission/contagion risk.

Sections du résumé

Background UNASSIGNED
Identifying determinants of the novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) transmission in settings of contagion is fundamental to inform containment strategies. We assessed SARS-CoV-2 cycle threshold value (Ct) from the first diagnostic nasal-pharyngeal swab of symptomatic index cases and which demographic or clinical characteristics among cases and contacts are associated with transmission risk within households.
Methods UNASSIGNED
This is a retrospective prevalence study on secondary SARS-CoV-2 cases (SC) among the household contacts of symptomatic adult index cases randomly sampled from all the SARS-CoV-2-positive diagnostic nasopharyngeal swabs analyzed at our regional referral hospital (Amedeo di Savoia Hospital, Turin, Italy) in March, 2020. Index cases underwent a telephone survey to collect their demographic and clinical data and all their household contacts. The Ct value of RdRp gene from the first diagnostic swab of index cases was recorded and index cases were grouped according to Ct tertiles (A < first tertile, first ≤ B ≤ second tertile, C ≥ second tertile).
Results UNASSIGNED
Index (
Conclusion UNASSIGNED
In confined transmission settings such as households, PCR Ct values may inform on the contagiousness of infected subjects and age may modulate transmission/contagion risk.

Identifiants

pubmed: 35432272
doi: 10.3389/fmicb.2022.829393
pmc: PMC9010948
doi:

Types de publication

Journal Article

Langues

eng

Pagination

829393

Informations de copyright

Copyright © 2022 Trunfio, Richiardi, Alladio, Staffilano, Longo, Venuti, Ghisetti, Burdino, Bonora, Vineis, Di Perri and Calcagno.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Front Psychol. 2020 Oct 21;11:559288
pubmed: 33192820
Sci Rep. 2021 Jun 4;11(1):11838
pubmed: 34088959
Elife. 2021 Sep 27;10:
pubmed: 34569939
J Infect. 2020 Jul;81(1):179-182
pubmed: 32283139
Lancet Infect Dis. 2021 May;21(5):629-636
pubmed: 33545090
Clin Infect Dis. 2022 Mar 9;74(5):821-828
pubmed: 34137815
J Infect Dis. 2021 Feb 13;223(3):362-369
pubmed: 33119738
J Infect Public Health. 2021 Sep;14(9):1201-1205
pubmed: 34416598
JAMA Netw Open. 2020 Dec 1;3(12):e2031756
pubmed: 33315116
Front Cell Dev Biol. 2020 Jul 10;8:618
pubmed: 32754600
Clin Infect Dis. 2021 Dec 6;73(11):e3884-e3899
pubmed: 33270107
PLoS One. 2020 Oct 8;15(10):e0240205
pubmed: 33031427
Environ Pollut. 2020 Oct;265(Pt B):115010
pubmed: 32570023
Nat Commun. 2021 Jan 11;12(1):267
pubmed: 33431879
Eur Arch Otorhinolaryngol. 2020 Sep;277(9):2637-2640
pubmed: 32449021
Lancet Infect Dis. 2021 May;21(5):617-628
pubmed: 33476567
Open Forum Infect Dis. 2021 Aug 31;8(9):ofab453
pubmed: 34584900
Lancet Infect Dis. 2022 Feb;22(2):183-195
pubmed: 34756186
JAMA Netw Open. 2021 Jan 4;4(1):e2035057
pubmed: 33410879
Viruses. 2021 Feb 11;13(2):
pubmed: 33670360
Clin Infect Dis. 2021 Oct 15;:
pubmed: 34651164
Front Microbiol. 2021 Mar 16;12:646679
pubmed: 33815334
Clin Infect Dis. 2022 Feb 11;74(3):407-415
pubmed: 33972994
Curr Ther Res Clin Exp. 2020;93:100607
pubmed: 33071295
PLoS One. 2021 Feb 16;16(2):e0247060
pubmed: 33592054
JAMA Netw Open. 2021 Aug 2;4(8):e2122240
pubmed: 34448865
Int J Epidemiol. 2022 Jan 6;50(6):1795-1803
pubmed: 34999848
Lancet Infect Dis. 2021 Jul;21(7):914-915
pubmed: 33864803
Clin Infect Dis. 2021 Aug 12;:
pubmed: 34383889
Ann Intern Med. 2020 Dec 1;173(11):879-887
pubmed: 32790510
Epidemiol Infect. 2020 Jul 07;148:e145
pubmed: 32631470
Nat Med. 2021 May;27(5):790-792
pubmed: 33782619
Lancet Infect Dis. 2021 Mar;21(3):333-343
pubmed: 33152271
Geroscience. 2021 Feb;43(1):19-29
pubmed: 33469835
Vaccines (Basel). 2021 Nov 23;9(12):
pubmed: 34960123
Lancet Infect Dis. 2020 Oct;20(10):1141-1150
pubmed: 32562601
PLoS One. 2020 Dec 9;15(12):e0243597
pubmed: 33296437
Eur J Clin Microbiol Infect Dis. 2020 Jun;39(6):1059-1061
pubmed: 32342252
J Infect Dis. 2021 Oct 28;224(8):1362-1371
pubmed: 33649773
J Infect. 2020 Dec;81(6):979-997
pubmed: 32858069
Euro Surveill. 2020 Aug;25(32):
pubmed: 32794447
Ann Intern Med. 2021 Jan;174(1):69-79
pubmed: 32941052

Auteurs

Mattia Trunfio (M)

Infectious Diseases Unit, Amedeo di Savoia Hospital, Department of Medical Sciences, University of Turin, Turin, Italy.

Lorenzo Richiardi (L)

Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy.

Francesca Alladio (F)

Infectious Diseases Unit, Amedeo di Savoia Hospital, Department of Medical Sciences, University of Turin, Turin, Italy.

Elena Staffilano (E)

Infectious Diseases Unit, Amedeo di Savoia Hospital, Department of Medical Sciences, University of Turin, Turin, Italy.

Bianca Longo (B)

Infectious Diseases Unit, Amedeo di Savoia Hospital, Department of Medical Sciences, University of Turin, Turin, Italy.

Francesco Venuti (F)

Infectious Diseases Unit, Amedeo di Savoia Hospital, Department of Medical Sciences, University of Turin, Turin, Italy.

Valeria Ghisetti (V)

Laboratory of Microbiology and Molecular Biology, Amedeo di Savoia Hospital, Turin, Italy.

Elisa Burdino (E)

Laboratory of Microbiology and Molecular Biology, Amedeo di Savoia Hospital, Turin, Italy.

Stefano Bonora (S)

Infectious Diseases Unit, Amedeo di Savoia Hospital, Department of Medical Sciences, University of Turin, Turin, Italy.

Paolo Vineis (P)

Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom.

Giovanni Di Perri (G)

Infectious Diseases Unit, Amedeo di Savoia Hospital, Department of Medical Sciences, University of Turin, Turin, Italy.

Andrea Calcagno (A)

Infectious Diseases Unit, Amedeo di Savoia Hospital, Department of Medical Sciences, University of Turin, Turin, Italy.

Classifications MeSH